Sponsor or institution
Clinical trials and research at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
As of November 12, 2026, Find a Trial lists 11 clinical trials run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. that are recruiting, in China. By phase: Phase 3 (5), Phase 2 (3), Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| 611 in Chinese children with moderate to severe atopic dermatitis | Phase 3 | Beijing, Beijing Municipality and 4 other locations | Recruiting | Aug 17, 2026 |
| SSGJ-716 first-in-human test in healthy adults and people with moderate-to-severe atopic dermatitis | Phase 1 | Shanghai | Recruiting | Jul 9, 2026 |
| 627 for moderate to severe ulcerative colitis: see if it helps | Phase 2 | Guangzhou, Guangdong | Recruiting | Apr 2, 2026 |
| Testing 608 in adults with active ankylosing spondylitis | Phase 3 | Beijing, Beijing Municipality | Recruiting | Dec 3, 2025 |
| 626 added to standard treatment for systemic lupus (SLE) | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Sep 22, 2025 |
| Testing 611 for moderate to severe atopic dermatitis in Chinese adolescents | Phase 3 | Beijing, Beijing Municipality and 2 other locations | Recruiting | Jun 27, 2025 |
| 611 for moderate-to-severe COPD in Chinese adults | Phase 3 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Jun 26, 2025 |
| Testing SSGJ-707 with chemotherapy for metastatic colorectal cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jul 10, 2024 |
| Evaluating SSGJ-705 for advanced malignant tumors | Phase 1 | Jinan, Shandong | Recruiting | Apr 30, 2024 |
| 610 for severe asthma in adults | Phase 3 | Shanghai, Shanghai Municipality | Recruiting | Mar 21, 2024 |
All recruiting trials (11)
-
611 in Chinese children with moderate to severe atopic dermatitis
A Phase 3 study tests whether 611 helps kids aged 2 to under 12 with moderate to severe atopic dermatitis compared with a placebo.
-
SSGJ-716 first-in-human test in healthy adults and people with moderate-to-severe atopic dermatitis
This early-phase study tests the safety and tolerability of SSGJ-716 in healthy adults and in people with moderate-to-severe atopic dermatitis.
-
627 for moderate to severe ulcerative colitis: see if it helps
This study tests whether 627 can help adults with moderate to severe ulcerative colitis who haven’t fully benefited from other therapies.
-
Testing 608 in adults with active ankylosing spondylitis
This trial tests whether the medicine 608 helps adults with active ankylosing spondylitis and is safe to use.
-
626 added to standard treatment for systemic lupus (SLE)
This trial will test whether adding the drug 626 to standard care reduces disease activity and is safe for adults with systemic lupus (SLE).
-
Testing 611 for moderate to severe atopic dermatitis in Chinese adolescents
This test will see if 611 helps Chinese adolescents (ages 12–17) with moderate to severe atopic dermatitis compared with a matching placebo over about 64 weeks.
-
611 for moderate-to-severe COPD in Chinese adults
This will test whether 611 reduces flare-ups and is safe for Chinese adults aged 40–85 with moderate to severe COPD who have had recent exacerbations.
-
Testing SSGJ-707 with chemotherapy for metastatic colorectal cancer
This study is testing a new treatment called SSGJ-707 with chemotherapy to see if it helps people with metastatic colorectal cancer feel better compared to another treatment option.
-
Evaluating SSGJ-705 for advanced malignant tumors
This study is testing a new treatment called SSGJ-705 to see if it is safe and effective for people with advanced cancer.
-
610 for severe asthma in adults
This trial will test whether 610 is safe and helps control severe asthma in Chinese adults.
-
Evaluating the effects of 608 in patients with non-radiographic axial spondyloarthritis
This study is testing a new treatment called 608 to see if it can help adults with non-radiographic axial spondyloarthritis feel better compared to a placebo.
Quick answers
How many clinical trials run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 5, Phase 2: 3, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.